$0.711
+0.014 (+1.94%)At close
QUCY Comparative Benchmarking
In the context of the broader market, QUCY competes directly with industry leaders such as MBOT and OKYO. With a market capitalization of $62.00M, it holds a significant position in the sector. When comparing efficiency, QUCY's gross margin of N/A stands against MBOT's -266.80% and OKYO's N/A. Such benchmarking helps identify whether Quantum Cyber NV is trading at a premium or discount relative to its financial performance.
Quantum Cyber NV Financial Performance
Mainz Biomed NV has reported total revenue of only $125,180 in Q3 2025, with a gross margin of 79.97% in that quarter, but has consistently posted negative net income, with losses exceeding $10 million in Q2 2026.
Financials
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.